Triazole derivative

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 249/12 (2006.01) A61K 31/4196 (2006.01) A61P 35/00 (2006.01) C07F 9/09 (2006.01) C07H 15/26 (2006.01)

Patent

CA 2675737

5-[4-(2-Methyl-phenyl)-3-hydroxy-4H-[1,2,4]triazol-5-yl]-2,4-dihydroxy-.LAMBDA./- methyl-.LAMBDA./-butyl-benzamide is an HSP90 inhibitor and can be used for producing a medicament for treating diseases in which the inhibition, regulation and/or modulation of HSP90 plays a role.

Le 5-[4-(2-méthyl-phényl)-3-hydroxy-4H-[1,2,4]triazol-5-yl]-2,4-dihydroxy-N-méthyl-N-butyl-benzamide est un inhibiteur de HSP90 et peut être utilisé pour produire un médicament destiné à traiter des maladies dans lesquelles l'inhibition, la régulation et/ou la modulation de HSP90 jouent un rôle.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Triazole derivative does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Triazole derivative, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Triazole derivative will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1647739

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.